- Reaction score
- 497
Yes, never had a conclusion either.Or searching for it in the forum. All this stuff has been discussed as far as I don't remember.
Yes, never had a conclusion either.Or searching for it in the forum. All this stuff has been discussed as far as I don't remember.
About release date? You must be kidding right. There are tons of speculations from tommorow to never ever. So anyone's guess is as good as mine. Still waiting for that crystal ball I ordered to answer all these random questions.Yes, never had a conclusion either.
You read the title of this post, right? You need glasses mateAbout release date? You must be kidding right. There are tons of speculations from tommorow to never ever. So anyone's guess is as good as mine. Still waiting for that crystal ball I ordered to answer all these random questions.
No worries. It's the estrogen mate!Guys tranny drugs made my vision blur
So when would we estimate the 7.5% solution for males to be released? (Considering the special FDA phase III filing)
Blocked. Serious answers or nothing, please.In stores by December 17 202(pick a digit from 1 to 9). Preorder now.
No worries. It's the estrogen mate!
SUMMER 2020 AVENGERS THE BREEZULAGAMEBlocked. Serious answers or nothing, please.
SUMMER 2020 AVENGERS THE BREEZULAGAME
So when would we estimate the 7.5% solution for males to be released in a best case scenario? (Considering the special FDA phase III filing)
Seems legit, unfortunately.Best case scenario: They start the trial in 01.09.2020 take half a year trial 01.03.2021 and wait one year for approval which takes in best case 1 year. So best case 01.03.2022.
Now lets take a look at a realistic timeline:
Start 01.09.2020
End of enrolement (sasumed needed 15 month for phase 3 enrolement) 01.12.2021
End of trial (6 month later) 01.06.2022
Getting approval (takes 12-18 month so lets assume 15) 01.09.2023
And that is really a realistic approximation and not a conservative. And keep in mind that half of the phase 3 trial candidates are droped by the developing company during or after the pase 3 trial and half of the ones, that are not droped are rejected by the fda.
So a realistically we have a 25% chance it hits the market 01.09.2023 and best case it hits the market 01.03.2022.